Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Stewart

Showing results (1-10 of 208) with videos related to

Pageof 21
Sort By:
Hematology (Amsterdam, Netherlands)|April 18, 2012
Novel therapeutics in multiple myelomaA Keith Stewart
Future Oncology (London, England)|July 1, 2015
Carfilzomib for the treatment of patients with relapsed and/or refractory multiple myelomaA Keith Stewart
Hematology. American Society of Hematology. Education Program|December 17, 2009
Novel therapies for relapsed myelomaA Keith Stewart
Molecular Cancer Therapeutics|March 17, 2007
Targeted therapeutics for multiple myeloma: the arrival of a risk-stratified approachRafael Fonseca, A Keith Stewart
Expert Review of Molecular Diagnostics|July 11, 2007
Review of molecular diagnostics in multiple myelomaA Keith Stewart, Rafael Fonseca
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2005
Prognostic and therapeutic significance of myeloma genetics and gene expression profilingA Keith Stewart, Rafael Fonseca
Expert Review of Hematology|January 11, 2014
Multiple myeloma: genome sequencing, drug development and the future outlookAlexander Keith Stewart, Jonathan Patience
Blood|February 9, 2013
CarfilzomibK Martin Kortuem, A Keith Stewart
Hematology. American Society of Hematology. Education Program|December 17, 2009
ASH evidence-based guidelines: what is the role of maintenance therapy in the treatment of multiple myeloma?Irene M Ghobrial, A Keith Stewart
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|February 25, 2005
Advances in myeloma genetics and prospects for pharmacogenomic testing in multiple myelomaJaime O Claudio, A Keith Stewart
Pageof 21

Showing results (1-10 of 208) with videos related to

Sort By:
Pageof 21
Hematology (Amsterdam, Netherlands)|April 18, 2012
Novel therapeutics in multiple myelomaA Keith Stewart
Future Oncology (London, England)|July 1, 2015
Carfilzomib for the treatment of patients with relapsed and/or refractory multiple myelomaA Keith Stewart
Hematology. American Society of Hematology. Education Program|December 17, 2009
Novel therapies for relapsed myelomaA Keith Stewart
Molecular Cancer Therapeutics|March 17, 2007
Targeted therapeutics for multiple myeloma: the arrival of a risk-stratified approachRafael Fonseca, A Keith Stewart
Expert Review of Molecular Diagnostics|July 11, 2007
Review of molecular diagnostics in multiple myelomaA Keith Stewart, Rafael Fonseca
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2005
Prognostic and therapeutic significance of myeloma genetics and gene expression profilingA Keith Stewart, Rafael Fonseca
Expert Review of Hematology|January 11, 2014
Multiple myeloma: genome sequencing, drug development and the future outlookAlexander Keith Stewart, Jonathan Patience
Blood|February 9, 2013
CarfilzomibK Martin Kortuem, A Keith Stewart
Hematology. American Society of Hematology. Education Program|December 17, 2009
ASH evidence-based guidelines: what is the role of maintenance therapy in the treatment of multiple myeloma?Irene M Ghobrial, A Keith Stewart
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|February 25, 2005
Advances in myeloma genetics and prospects for pharmacogenomic testing in multiple myelomaJaime O Claudio, A Keith Stewart
Pageof 21